Institute for Environmental Health, Inc.

Sample6 Technologies, Inc.

Massachusetts Institute of Technology

Battelle Memorial Institute

Boston University

Phage Diagnostics, Inc.

Michael Sandor Koeris

Daniel Robert Brownell

Jayson Linn Bowers

Robert Patrick Shivers

Jason Wyatt Holder

Edyta Krzymanska-Olejnik

Michael Cappillino

Timothy Kuan Ta Lu

James Joseph Collins

Gregory N Stephanopoulos

Timothy Kuan-Ta Lu

Anthony David Duong

Gregory McKenzie

Cherry Gupta

Danielle J Huk

Kenneth R Sims, Jr

Brett Chevalier

Andrea D Mccue

Tanguy My Chau

Ashlee J Colbert

Zachary R Shank

Christopher Jongsoo Yoon

Julie Thomason

Emma K Schmitz

Caleb T Hillrich

Shannon D Miller

Joanna L Hoy

Gregory John McKenzie

Timothy Kuan Lu

Brett Smith Chevalier

Gregory John Mckenzie

The disclosure relates to barcoded polymer nanoparticles for in vivo screening and for in vivo therapeutic delivery, and methods therefor. More particularly, the invention relates to polymer nanoparticles, such as reversible addition-fragmentation chain transfer (RAFT) polymer compositions, associated with polynucleotide barcodes, for therapeutic delivery, and for high throughput in vivo screening of drug delivery nanoparticles.

Rapid design, build, test, and learn technologies for identifying and using non-viral carriers

The present invention is generally related to engineered bacteriophages expressing antimicrobial peptides or lytic enzymes or fragments thereof for targeting a broad spectrum of bacterial hosts, and for the long-term suppression of bacterial phage resistance for reducing bacterial infections. In some embodiments, bacteriophages express antimicrobial peptides or antimicrobial polypeptides (e.g. phage lytic enzymes) which are secreted from the host bacteria, or alternatively released upon lysis of the bacterial host cell. Aspects of the present invention also relate to the use of the engineered bacteriophages for the reduction of bacterial infections, both in a subject or for bioremediation purposes, in clinical settings and wound healing.

Bacteriophages expressing antimicrobial peptides and uses thereof

Methods of detecting target bacteria are provided. In some embodiments, the methods comprise exposing a sample to a phage capable of infecting target bacteria, said phage comprising a heterologous nucleic acid sequence encoding a marker. In some embodiments, the target bacteria comprise. In some embodiments, the target bacteria are all. Recombinantphage comprising a heterologous nucleic acid sequence encoding a marker are also provided as are useful combinations of such phage and articles of manufacture comprising such phage, among other things.

Recombinant phage for listeria detection

Composition and methods for the detection of one or more target microbe(s) are provided. Compositions of the disclosure include at least one recombinant phage capable of infecting a target microbe, said phage comprising at least a capsid protein sequence, a ribosome binding site, and a codon-optimized marker. Compositions of the disclosure may further include an aqueous solution that enhances the ability to detect marker expression upon phage infection of the target microbe. In some embodiments the target microbe include is

Codon optimized recombinant phage and methods of using same

Methods of detecting target bacteria are provided. In some embodiments the methods comprise exposing the sample to a phage capable of infecting a set of target bacteria and comprising a heterologous nucleic acid sequence encoding a marker. In some embodiments the target bacteria comprise. In some embodiments the target bacteria are all. Recombinantphage comprising a heterologous nucleic acid sequence encoding a marker are also provided as are useful combinations of such phage and articles of manufacture comprising such phage, among other things.

Phage-based bacterial detection assay

Methods of making recombinant phage, compositions and articles of manufacture of same for bacterial detection

This disclosure provided methods of cloning a phage genome. Also provided are methods of making a recombinant phage genome. In some embodiments the phage genome is engineered to comprise a heterologous nucleic acid sequence, for example a sequence comprising an open reading frame. In some embodiments the phage genome is cloned in a yeast artificial chromosome. Recombinant phage genomes and recombinant phage are also provided. In some embodiments the methods are high throughput methods such as methods of making a plurality of recombinant phage genomes or recombinant phage. Collections of recombinant phage genomes and recombinant phage are also provided.

Recombinant phage and methods

Growing community of inventors

Natick, MA, United States of America

Michael Sandor Koeris